Condition: Cardiac Sarcoidosis · Sarcoidosis · Sponsor: Ottawa Heart Institute Research Corporation
Prospective randomized controlled trial comparing low dose Prednisone(or Prednisolone)/Methotrexate combination to standard dose Prednisone(or Prednisolone) in patients diagnosed with acute active clinically manifest cardiac sarcoidosis and not yet treated. The Investigators hypothesize that low dose Prednisone(or Prednisolone)/Methotrexate combination will be as effective as standard dose Prednisone(or Prednisolone), and result in significantly better quality of life and less toxicity than standard dose Prednisone(or Prednisolone).
This description comes directly from the study's public registry record.
David H Birnie, MD · 613-696-7269 · dbirnie@ottawaheart.ca
Janine Ryan, BAH, CCRP · 613-696-7000 · jryan@ottawaheart.ca
Always discuss trial participation with your own doctor first.
| Yale-New Haven Hospital | New Haven, Connecticut, United States | Recruiting |
| Tufts Medical Center | Boston, Massachusetts, United States | Recruiting |
| University of Michigan-Michigan Medicine Cardiovascular Center | Ann Arbor, Michigan, United States | Recruiting |
| University of Minnesota | Minneota, Minnesota, United States | Not Yet Recruiting |
| Montefiore Medical Center | New York, New York, United States | Recruiting |
| The Ohio State University Wexner Medical Center | Columbus, Ohio, United States | Recruiting |
| Allegheny General Hospital | Pittsburgh, Pennsylvania, United States | Recruiting |
| University of Utah | Salt Lake City, Utah, United States | Recruiting |
| Virginia Commonwealth University | Richmond, Virginia, United States | Recruiting |
| Libin Cardiovascular Institute of Alberta | Calgary, Alberta, Canada | Recruiting |
| St. Paul's Hospital | Vancouver, British Columbia, Canada | Recruiting |
| Eastern Health Health Sciences Centre | St. John's, Newfoundland and Labrador, Canada | Recruiting |
+ 19 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03593759